ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Gus J. Vlahakes
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vlahakes, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vlahakes, G. J.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;61:1051-1052
© 1996 The Society of Thoracic Surgeons

Editorial

Management of Pulmonary Hypertension and Right Ventricular Failure: Another Step Forward

Gus J. Vlahakes, MD

Department of Surgery, Harvard Medical School and Massachusetts General Hospital, Boston, Massachusetts

The first 20% of the full text of this article appears below.

The study by Fullerton and associates [1] published in this issue of The Annals represents a significant step forward in the management of right heart failure. This clinical problem has vexed cardiac surgeons for decades, initially in the setting of operations for advanced mitral valve disease, after embolectomy for acute pulmonary embolism, and after certain operations for congenital heart disease. In recent decades, right heart failure has been recognized as a significant source of morbidity and mortality after heart transplantation, and after the institution of left ventricular mechanical assistance. Techniques to manage this often difficult problem can greatly benefit these clinical areas.

The traditional therapeutic strategies for managing right heart failure have focused on the use of various agents that decrease pulmonary vascular resistance and therefore, right heart afterload. However, until recently, vasodilator agents used to treat right heart failure were nonspecific; that is, agents such as tolazoline, nitroprusside, or nitroglycerin dilate not only the . . . [Full Text of this Article]


Related Article

Adenosine Effectively Controls Pulmonary Hypertension After Cardiac Operations
David A. Fullerton, Stephen D. Jones, Frederick L. Grover, and Robert C. McIntyre, Jr
Ann. Thorac. Surg. 1996 61: 1118-1123. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
F. Haddad, P. Couture, C. Tousignant, and A. Y. Denault
The Right Ventricle in Cardiac Surgery, a Perioperative Perspective: II. Pathophysiology, Clinical Importance, and Management
Anesth. Analg., February 1, 2009; 108(2): 422 - 433.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
Y. Jeon, J. H. Ryu, Y. J. Lim, C. S. Kim, J.-H. Bahk, S. Z. Yoon, and J. Y. Choi
Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 952 - 956.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
L. G. Fischer, H. V. Aken, and H. Burkle
Management of Pulmonary Hypertension: Physiological and Pharmacological Considerations for Anesthesiologists
Anesth. Analg., June 1, 2003; 96(6): 1603 - 1616.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.